539206 — Genomic Valley Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹104.77m
- IN₹104.51m
- IN₹2.68m
Annual cashflow statement for Genomic Valley Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Preliminary |
| Net Income/Starting Line | -4.21 | 9.13 | 0.151 | 4.41 | 0.4 |
| Depreciation | |||||
| Non-Cash Items | -3.41 | -0.425 | -0.015 | -0.045 | 0 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -14.5 | -16.6 | -0.348 | -4.12 | -0.627 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -21.3 | -7.79 | -0.201 | 0.272 | -0.19 |
| Capital Expenditures | — | — | — | -0.092 | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 36.7 | 15.2 | -0.152 | 0.211 | 0 |
| Sale of Fixed Assets | |||||
| Change in Net Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 36.7 | 15.2 | -0.152 | 0.12 | 0 |
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -15.5 | -7.04 | 0 | 0 | 0 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.088 | 0.386 | -0.352 | 0.392 | -0.19 |